An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumour. Oncolytic viruses are thought not only to cause direct destruction of the tumour cells, but also to stimulate host anti-tumour immune system responses.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Oncolytic Virus Therapy industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Market Segment by Product Application
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Amgen
SillaJen Biotherapeutics
Transgene SA
Oncolytics Biotech
PsiOxus Therapeutics
Viralytics
Lokon Pharma
Targovax
Oncolys BioPharma
Sorrento Therapeutics
Genelux Corporation
Cold Genesys
Vyriad
TILT Biotherapeutics
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Oncolytic Virus Therapy consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Oncolytic Virus Therapy market by identifying its various subsegments.
3.Focuses on the key global Oncolytic Virus Therapy manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Oncolytic Virus Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Oncolytic Virus Therapy submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Oncolytic Virus Therapy Market Status and Outlook 2022-2027
Market Study Overview
1.1 Study Objectives
1.2 Oncolytic Virus Therapy Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Oncolytic Virus Therapy Segment by Type
2.1.1 HSV-based Oncolytic Viruses
2.1.2 Adenoviruses-based Oncolytic Viruses
2.1.3 Vaccinia Virus-based Oncolytic Viruses
2.1.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
2.1.5 Newcastle Disease Virus-based Oncolytic Viruses
2.2 Market Analysis by Application
2.2.1 Melanoma
2.2.2 Prostate Cancer
2.2.3 Breast Cancer
2.2.4 Ovarian Cancer
2.2.5 Others
2.3 Global Oncolytic Virus Therapy Market Comparison by Regions (2017-2027)
2.3.1 Global Oncolytic Virus Therapy Market Size (2017-2027)
2.3.2 North America Oncolytic Virus Therapy Status and Prospect (2017-2027)
2.3.3 Europe Oncolytic Virus Therapy Status and Prospect (2017-2027)
2.3.4 Asia-pacific Oncolytic Virus Therapy Status and Prospect (2017-2027)
2.3.5 South America Oncolytic Virus Therapy Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Oncolytic Virus Therapy Status and Prospect (2017-2027)
2.5 Coronavirus Disease 2019 (Covid-19): Oncolytic Virus Therapy Industry Impact
2.5.1 Oncolytic Virus Therapy Business Impact Assessment - Covid-19
2.5.2 Market Trends and Oncolytic Virus Therapy Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Vendors
3.1 Global Oncolytic Virus Therapy Revenue and Market Share by Vendors (2017-2022)
3.2 Global Oncolytic Virus Therapy Industry Concentration Ratio (CR5 and HHI)
3.3 Top 5 Oncolytic Virus Therapy Vendors Market Share
3.4 Top 10 Oncolytic Virus Therapy Vendors Market Share
3.5 Date of Key Vendors Enter into Oncolytic Virus Therapy Market
3.6 Key Vendors Oncolytic Virus Therapy Product Offered
3.7 Mergers & Acquisitions Planning
4 Analysis of Oncolytic Virus Therapy Industry Key Vendors
4.1 Amgen
4.1.1 Company Details
4.1.2 Product Introduction, Application and Specification
4.1.3 Amgen Oncolytic Virus Therapy Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Amgen News
4.2 SillaJen Biotherapeutics
4.2.1 Company Details
4.2.2 Product Introduction, Application and Specification
4.2.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 SillaJen Biotherapeutics News
4.3 Transgene SA
4.3.1 Company Details
4.3.2 Product Introduction, Application and Specification
4.3.3 Transgene SA Oncolytic Virus Therapy Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Transgene SA News
4.4 Oncolytics Biotech
4.4.1 Company Details
4.4.2 Product Introduction, Application and Specification
4.4.3 Oncolytics Biotech Oncolytic Virus Therapy Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Oncolytics Biotech News
4.5 PsiOxus Therapeutics
4.5.1 Company Details
4.5.2 Product Introduction, Application and Specification
4.5.3 PsiOxus Therapeutics Oncolytic Virus Therapy Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 PsiOxus Therapeutics News
4.6 Viralytics
4.6.1 Company Details
4.6.2 Product Introduction, Application and Specification
4.6.3 Viralytics Oncolytic Virus Therapy Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Viralytics News
4.7 Lokon Pharma
4.7.1 Company Details
4.7.2 Product Introduction, Application and Specification
4.7.3 Lokon Pharma Oncolytic Virus Therapy Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Lokon Pharma News
4.8 Targovax
4.8.1 Company Details
4.8.2 Product Introduction, Application and Specification
4.8.3 Targovax Oncolytic Virus Therapy Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Targovax News
4.9 Oncolys BioPharma
4.9.1 Company Details
4.9.2 Product Introduction, Application and Specification
4.9.3 Oncolys BioPharma Oncolytic Virus Therapy Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Oncolys BioPharma News
4.10 Sorrento Therapeutics
4.10.1 Company Details
4.10.2 Product Introduction, Application and Specification
4.10.3 Sorrento Therapeutics Oncolytic Virus Therapy Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Sorrento Therapeutics News
4.11 Genelux Corporation
4.11.1 Company Details
4.11.2 Product Introduction, Application and Specification
4.11.3 Genelux Corporation Oncolytic Virus Therapy Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Genelux Corporation News
4.12 Cold Genesys
4.12.1 Company Details
4.12.2 Product Introduction, Application and Specification
4.12.3 Cold Genesys Oncolytic Virus Therapy Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Cold Genesys News
4.13 Vyriad
4.13.1 Company Details
4.13.2 Product Introduction, Application and Specification
4.13.3 Vyriad Oncolytic Virus Therapy Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Vyriad News
4.14 TILT Biotherapeutics
4.14.1 Company Details
4.14.2 Product Introduction, Application and Specification
4.14.3 TILT Biotherapeutics Oncolytic Virus Therapy Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 TILT Biotherapeutics News
5 Global Oncolytic Virus Therapy Market Size Categorized by Regions
5.1 Global Oncolytic Virus Therapy Revenue and Market Share by Regions
5.2 North America Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
5.3 Europe Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
5.4 Asia-pacific Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
5.5 South America Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
5.6 Middle East & Africa Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
6 North America Oncolytic Virus Therapy Market Size Categorized by Countries
6.1 North America Oncolytic Virus Therapy Revenue and Market Share by Countries
6.1.1 North America Oncolytic Virus Therapy Market Size by Countries (2017-2022)
6.1.2 United States Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
6.1.3 Canada Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
6.1.4 Mexico Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
6.2 North America Oncolytic Virus Therapy Revenue (Value) by Vendors
6.3 North America Oncolytic Virus Therapy Revenue and Market Share by Type (2017-2022)
6.4 North America Oncolytic Virus Therapy Revenue and Market Share by Application (2017-2022)
7 Europe Oncolytic Virus Therapy Market Size Categorized by Countries
7.1 Europe Oncolytic Virus Therapy Revenue and Market Share by Countries
7.1.1 Europe Oncolytic Virus Therapy Market Size by Countries (2017-2022)
7.1.2 Germany Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
7.1.3 UK Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
7.1.4 France Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
7.1.5 Russia Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
7.1.6 Italy Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
7.1.7 Spain Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
7.2 Europe Oncolytic Virus Therapy Revenue (Value) by Vendors
7.3 Europe Oncolytic Virus Therapy Revenue and Market Share by Type (2017-2022)
7.4 Europe Oncolytic Virus Therapy Revenue and Market Share by Application (2017-2022)
8 Asia-pacific Oncolytic Virus Therapy Market Size Categorized by Countries
8.1 Asia-pacific Oncolytic Virus Therapy Revenue and Market Share by Countries
8.1.1 Asia-pacific Oncolytic Virus Therapy Market Size by Countries (2017-2022)
8.1.2 China Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
8.1.3 South Korea Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
8.1.4 Japan Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
8.1.5 Australia Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
8.1.6 India Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
8.1.7 Southeast Asia Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
8.2 Asia-pacific Oncolytic Virus Therapy Revenue (Value) by Vendors
8.3 Asia-pacific Oncolytic Virus Therapy Revenue and Market Share by Type (2017-2022)
8.4 Asia-pacific Oncolytic Virus Therapy Revenue and Market Share by Application (2017-2022)
9 South America Oncolytic Virus Therapy Market Size Categorized by Countries
9.1 South America Oncolytic Virus Therapy Revenue and Market Share by Countries
9.1.1 South America Oncolytic Virus Therapy Market Size by Countries (2017-2022)
9.1.2 Brazil Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
9.1.3 Chile Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
9.2 South America Oncolytic Virus Therapy Revenue and Market Share by Type (2017-2022)
9.3 South America Oncolytic Virus Therapy Revenue and Market Share by Application (2017-2022)
10 Middle East and Africa Oncolytic Virus Therapy Market Size Categorized by Countries
10.1 Middle East and Africa Oncolytic Virus Therapy Revenue and Market Share by Countries
10.1.1 Middle East and Africa Oncolytic Virus Therapy Market Size by Countries (2017-2022)
10.1.2 GCC Countries Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
10.1.3 Turkey Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
10.1.4 Egypt Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
10.1.5 South Africa Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
10.2 Middle East and Africa Oncolytic Virus Therapy Revenue and Market Share by Type
10.3 Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Application (2017-2022)
11 Global Oncolytic Virus Therapy Market Segment by Type
11.1 Global Oncolytic Virus Therapy Revenue and Market Share by Type (2017-2022)
11.2 HSV-based Oncolytic Viruses Revenue Growth Rate and Price
11.3 Adenoviruses-based Oncolytic Viruses Revenue Growth Rate and Price
11.4 Vaccinia Virus-based Oncolytic Viruses Revenue Growth Rate and Price
11.5 Vesicular Stomatitis Virus-based Oncolytic Viruses Revenue Growth Rate and Price
11.6 Newcastle Disease Virus-based Oncolytic Viruses Revenue Growth Rate and Price
12 Global Oncolytic Virus Therapy Market Segment by Application
12.1 Global Oncolytic Virus Therapy Revenue Market Share by Application (2017-2022)
12.2 Melanoma Revenue Growth Rate (2017-2022)
12.3 Prostate Cancer Revenue Growth Rate (2017-2022)
12.4 Breast Cancer Revenue Growth Rate (2017-2022)
12.5 Ovarian Cancer Revenue Growth Rate (2017-2022)
12.6 Others Revenue Growth Rate (2017-2022)
13 Global Oncolytic Virus Therapy Market Forecast
13.1 Global Oncolytic Virus Therapy Revenue and Growth Rate (2022-2027)
13.2 Oncolytic Virus Therapy Market Forecast by Regions (2022-2027)
13.2.1 North America Oncolytic Virus Therapy Market Forecast (2022-2027)
13.2.2 Europe Oncolytic Virus Therapy Market Forecast (2022-2027)
13.2.3 Asia-Pacific Oncolytic Virus Therapy Market Forecast (2022-2027)
13.2.4 South America Oncolytic Virus Therapy Market Forecast (2022-2027)
13.2.5 Middle East & Africa Oncolytic Virus Therapy Market Forecast (2022-2027)
13.3 Oncolytic Virus Therapy Market Forecast by Type (2022-2027)
13.3.1 Global Oncolytic Virus Therapy Revenue Forecast by Type (2022-2027)
13.3.2 Global Oncolytic Virus Therapy Market Share Forecast by Type (2022-2027)
13.4 Oncolytic Virus Therapy Market Forecast by Application (2022-2027)
13.4.1 Global Oncolytic Virus Therapy Revenue Forecast by Application (2022-2027)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Downstream Market Analysis
15.1 Macro Analysis of Down Markets
15.2 Key Players in Down Markets
16 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Oncolytic Virus Therapy
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Oncolytic Virus Therapy Market Size (Million US$) by Type
Figure Global Market Share of Oncolytic Virus Therapy by Type in 2021
Figure HSV-based Oncolytic Viruses Picture
Figure Adenoviruses-based Oncolytic Viruses Picture
Figure Vaccinia Virus-based Oncolytic Viruses Picture
Figure Vesicular Stomatitis Virus-based Oncolytic Viruses Picture
Figure Newcastle Disease Virus-based Oncolytic Viruses Picture
Table Global Oncolytic Virus Therapy Market Size (Million US$) by Application
Figure Global Oncolytic Virus Therapy Market Share by Application in 2021
Figure Melanoma Picture
Figure Prostate Cancer Picture
Figure Breast Cancer Picture
Figure Ovarian Cancer Picture
Figure Others Picture
Table Global Oncolytic Virus Therapy Comparison by Regions (M USD) 2017-2027
Figure Global Oncolytic Virus Therapy Market Size (Million US$) (2017-2027)
Figure North America Oncolytic Virus Therapy Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Oncolytic Virus Therapy Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Oncolytic Virus Therapy Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Oncolytic Virus Therapy Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Oncolytic Virus Therapy Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Oncolytic Virus Therapy Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Oncolytic Virus Therapy Revenue by Vendors (2017-2022)
Figure Global Oncolytic Virus Therapy Revenue Market Share by Vendors in 2021
Table Global Oncolytic Virus Therapy Vendors Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Oncolytic Virus Therapy Vendors (Revenue) Market Share in 2021
Figure Top 10 Oncolytic Virus Therapy Vendors (Revenue) Market Share in 2021
Table Date of Key Vendors Enter into Oncolytic Virus Therapy Market
Table Key Vendors Oncolytic Virus Therapy Product Type
Table Amgen Company Profile
Table Oncolytic Virus Therapy Product Introduction, Application and Specification of Amgen
Table Oncolytic Virus Therapy Revenue (M USD) and Gross Margin of Amgen 2017-2022
Table Amgen Main Business
Table Amgen Recent Development
Table SillaJen Biotherapeutics Company Profile
Table Oncolytic Virus Therapy Product Introduction, Application and Specification of SillaJen Biotherapeutics
Table Oncolytic Virus Therapy Revenue (M USD) and Gross Margin of SillaJen Biotherapeutics 2017-2022
Table SillaJen Biotherapeutics Main Business
Table SillaJen Biotherapeutics Recent Development
Table SillaJen Biotherapeutics Company Profile
Table Oncolytic Virus Therapy Product Introduction, Application and Specification of SillaJen Biotherapeutics
Table Oncolytic Virus Therapy Revenue (M USD) and Gross Margin of SillaJen Biotherapeutics 2017-2022
Table SillaJen Biotherapeutics Main Business
Table SillaJen Biotherapeutics Recent Development
Table Transgene SA Company Profile
Table Oncolytic Virus Therapy Product Introduction, Application and Specification of Transgene SA
Table Oncolytic Virus Therapy Revenue (M USD) and Gross Margin of Transgene SA 2017-2022
Table Transgene SA Main Business
Table Transgene SA Recent Development
Table Oncolytics Biotech Company Profile
Table Oncolytic Virus Therapy Product Introduction, Application and Specification of Oncolytics Biotech
Table Oncolytic Virus Therapy Revenue (M USD) and Gross Margin of Oncolytics Biotech 2017-2022
Table Oncolytics Biotech Main Business
Table Oncolytics Biotech Recent Development
Table PsiOxus Therapeutics Company Profile
Table Oncolytic Virus Therapy Product Introduction, Application and Specification of PsiOxus Therapeutics
Table Oncolytic Virus Therapy Revenue (M USD) and Gross Margin of PsiOxus Therapeutics 2017-2022
Table PsiOxus Therapeutics Main Business
Table PsiOxus Therapeutics Recent Development
Table Viralytics Company Profile
Table Oncolytic Virus Therapy Product Introduction, Application and Specification of Viralytics
Table Oncolytic Virus Therapy Revenue (M USD) and Gross Margin of Viralytics 2017-2022
Table Viralytics Main Business
Table Viralytics Recent Development
Table Lokon Pharma Company Profile
Table Oncolytic Virus Therapy Product Introduction, Application and Specification of Lokon Pharma
Table Oncolytic Virus Therapy Revenue (M USD) and Gross Margin of Lokon Pharma 2017-2022
Table Lokon Pharma Main Business
Table Lokon Pharma Recent Development
Table Targovax Company Profile
Table Oncolytic Virus Therapy Product Introduction, Application and Specification of Targovax
Table Oncolytic Virus Therapy Revenue (M USD) and Gross Margin of Targovax 2017-2022
Table Targovax Main Business
Table Targovax Recent Development
Table Oncolys BioPharma Company Profile
Table Oncolytic Virus Therapy Product Introduction, Application and Specification of Oncolys BioPharma
Table Oncolytic Virus Therapy Revenue (M USD) and Gross Margin of Oncolys BioPharma 2017-2022
Table Oncolys BioPharma Main Business
Table Oncolys BioPharma Recent Development
Table Sorrento Therapeutics Company Profile
Table Oncolytic Virus Therapy Product Introduction, Application and Specification of Sorrento Therapeutics
Table Oncolytic Virus Therapy Revenue (M USD) and Gross Margin of Sorrento Therapeutics 2017-2022
Table Sorrento Therapeutics Main Business
Table Sorrento Therapeutics Recent Development
Table Genelux Corporation Company Profile
Table Oncolytic Virus Therapy Product Introduction, Application and Specification of Genelux Corporation
Table Oncolytic Virus Therapy Revenue (M USD) and Gross Margin of Genelux Corporation 2017-2022
Table Genelux Corporation Main Business
Table Genelux Corporation Recent Development
Table Cold Genesys Company Profile
Table Oncolytic Virus Therapy Product Introduction, Application and Specification of Cold Genesys
Table Oncolytic Virus Therapy Revenue (M USD) and Gross Margin of Cold Genesys 2017-2022
Table Cold Genesys Main Business
Table Cold Genesys Recent Development
Table Vyriad Company Profile
Table Oncolytic Virus Therapy Product Introduction, Application and Specification of Vyriad
Table Oncolytic Virus Therapy Revenue (M USD) and Gross Margin of Vyriad 2017-2022
Table Vyriad Main Business
Table Vyriad Recent Development
Table TILT Biotherapeutics Company Profile
Table Oncolytic Virus Therapy Product Introduction, Application and Specification of TILT Biotherapeutics
Table Oncolytic Virus Therapy Revenue (M USD) and Gross Margin of TILT Biotherapeutics 2017-2022
Table TILT Biotherapeutics Main Business
Table TILT Biotherapeutics Recent Development
Table Mergers & Acquisitions Planning
Figure Global Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure Global Oncolytic Virus Therapy Revenue by Regions (2017-2022)
Figure Global Oncolytic Virus Therapy Revenue Market Share by Regions in 2021
Figure North America Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure Europe Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure Asia-pacific Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure South America Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure Middle East & Africa Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure North America Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Table North America Oncolytic Virus Therapy Market Size by Countries (2017-2022)
Table North America Oncolytic Virus Therapy Market Share by Countries (2017-2022)
Figure North America Oncolytic Virus Therapy Market Share by Countries in 2021
Figure United States Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure Canada Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure Mexico Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Table North America Oncolytic Virus Therapy Revenue by Vendors (2021)
Figure North America Oncolytic Virus Therapy Revenue Market Share by Vendors in 2021
Table North America Oncolytic Virus Therapy Revenue by Type (2017-2022)
Table North America Oncolytic Virus Therapy Share by Type (2017-2022)
Table North America Oncolytic Virus Therapy Revenue by Application (2017-2022)
Table North America Oncolytic Virus Therapy Revenue Share by Application (2017-2022)
Figure Europe Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Table Europe Oncolytic Virus Therapy Market Size by Countries (2017-2022)
Table Europe Oncolytic Virus Therapy Revenue Market Share by Countries (2017-2022)
Figure Europe Oncolytic Virus Therapy Revenue Market Share by Countries in 2021
Figure Germany Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure UK Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure France Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure Russia Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure Italy Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure Spain Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Table Europe Oncolytic Virus Therapy Revenue by Vendors (2021)
Figure Europe Oncolytic Virus Therapy Revenue Market Share by Vendors in 2021
Table Europe Oncolytic Virus Therapy Revenue by Type (2017-2022)
Table Europe Oncolytic Virus Therapy Revenue Share by Type (2017-2022)
Table Europe Oncolytic Virus Therapy Revenue by Application (2017-2022)
Table Europe Oncolytic Virus Therapy Revenue Share by Application (2017-2022)
Figure Asia-pacific Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Table Asia-pacific Oncolytic Virus Therapy Market Size by Countries (2017-2022)
Table Asia-pacific Oncolytic Virus Therapy Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Oncolytic Virus Therapy Revenue Market Share by Countries in 2021
Figure China Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure South Korea Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure Japan Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure Australia Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure India Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure Southeast Asia Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Table Asia-pacific Oncolytic Virus Therapy Revenue by Vendors (2021)
Figure Asia-pacific Oncolytic Virus Therapy Revenue Market Share by Vendors in 2021
Table Asia-pacific Oncolytic Virus Therapy Revenue by Type (2017-2022)
Table Asia-pacific Oncolytic Virus Therapy Revenue Share by Type (2017-2022)
Table Asia-pacific Oncolytic Virus Therapy Revenue by Application (2017-2022)
Table Asia-pacific Oncolytic Virus Therapy Revenue Share by Application (2017-2022)
Figure South America Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Table South America Oncolytic Virus Therapy Revenue Market Size by Countries (2017-2022)
Table South America Oncolytic Virus Therapy Revenue Market Share by Countries (2017-2022)
Figure South America Oncolytic Virus Therapy Revenue Market Share by Countries in 2019
Figure Brazil Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure Chile Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Table South America Oncolytic Virus Therapy Revenue s by Type (2017-2022)
Table South America Oncolytic Virus Therapy Revenue Share by Type (2017-2022)
Table South America Oncolytic Virus Therapy Revenue by Application (2017-2022)
Table South America Oncolytic Virus Therapy Revenue Share by Application (2017-2022)
Figure Middle East and Africa Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Oncolytic Virus Therapy Market Size by Countries (2017-2022)
Table Middle East and Africa Oncolytic Virus Therapy Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Oncolytic Virus Therapy Sales Market Share by Countries in 2019
Figure GCC Countries Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure Turkey Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure Egypt Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Figure South Africa Oncolytic Virus Therapy Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Oncolytic Virus Therapy Revenue by Type (2017-2022)
Table Middle East and Africa Oncolytic Virus Therapy Revenue Share by Type (2017-2022)
Table Middle East and Africa Oncolytic Virus Therapy Revenue by Application (2017-2022)
Table Middle East and Africa Oncolytic Virus Therapy Revenue Share by Application (2017-2022)
Table Global Oncolytic Virus Therapy Revenue by Type (2017-2022)
Table Global Oncolytic Virus Therapy Revenue Market Share by Type (2017-2022)
Figure Global Oncolytic Virus Therapy Revenue Market Share by Type in 2019
Figure Global HSV-based Oncolytic Viruses Revenue and Growth Rate (2017-2022)
Figure Global Adenoviruses-based Oncolytic Viruses Revenue and Growth Rate (2017-2022)
Figure Global Vaccinia Virus-based Oncolytic Viruses Revenue and Growth Rate (2017-2022)
Figure Global Vesicular Stomatitis Virus-based Oncolytic Viruses Revenue and Growth Rate (2017-2022)
Figure Global Newcastle Disease Virus-based Oncolytic Viruses Revenue and Growth Rate (2017-2022)
Table Global Oncolytic Virus Therapy Revenue by Application (2017-2022)
Table Global Oncolytic Virus Therapy Revenue Market Share by Application (2017-2022)
Figure Global Oncolytic Virus Therapy Revenue Market Share by Application in 2021
Figure Global Melanoma Revenue Growth Rate (2017-2022)
Figure Global Prostate Cancer Revenue Growth Rate (2017-2022)
Figure Global Breast Cancer Revenue Growth Rate (2017-2022)
Figure Global Ovarian Cancer Revenue Growth Rate (2017-2022)
Figure Global Others Revenue Growth Rate (2017-2022)
Figure Global Oncolytic Virus Therapy Revenue and Growth Rate (2022-2027)
Table Global Oncolytic Virus Therapy Revenue Forecast by Regions (2022-2027)
Table Global Oncolytic Virus Therapy Market Share Forecast by Regions (2022-2027)
Figure North America Revenue Oncolytic Virus Therapy Market Forecast (2022-2027)
Figure Europe Revenue Oncolytic Virus Therapy Market Forecast (2022-2027)
Figure Asia-Pacific Revenue Oncolytic Virus Therapy Market Forecast (2022-2027)
Figure South America Revenue Oncolytic Virus Therapy Market Forecast (2022-2027)
Figure Middle East & Africa Revenue Oncolytic Virus Therapy Market Forecast (2022-2027)
Table Global Oncolytic Virus Therapy Revenue Forecast by Type (2022-2027)
Table Global Oncolytic Virus Therapy Market Share Forecast by Type (2022-2027)
Table Global Oncolytic Virus Therapy Revenue Forecast by Application (2022-2027)
Table Global Oncolytic Virus Therapy Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Author List
Amgen
SillaJen Biotherapeutics
Transgene SA
Oncolytics Biotech
PsiOxus Therapeutics
Viralytics
Lokon Pharma
Targovax
Oncolys BioPharma
Sorrento Therapeutics
Genelux Corporation
Cold Genesys
Vyriad
TILT Biotherapeutics
Global Brain-inspired Computing Market G..
The global market for Brain-inspired Computing is estimated ..
+16467917070US (Toll Free)